Protein Electrophile-Binding Motifs: Lysine-Rich Proteins Are Preferential Targets of Quinones

Quinones represent an important class of endogenous compounds such as neurotransmitters and coenzyme Q10, electrophilic xenobiotics, and environmental toxicants that have known reactivity based on their ability to redox cycle and generate oxidative stress, as well as to alkylate target proteins. It is likely that topological, chemical, and physical features combine to determine which proteins become targets for chemical adduction. Chemical-induced post-translational modification of certain critical proteins causes a change in structure/function that contributes to the toxicological response to chemical exposure. In this study, we have identified a number of proteins that are modified by quinone-thioethers after administration of 2-(glutathion-S-yl)HQ. Parallel one-dimensional gel electrophoresis was performed, and the Coomassie-stained gel was aligned with the corresponding Western blot, which was probed for adductions. Immunopositive bands were then subjected to trypsin digestion and analyzed via liquid chromatography/tandem mass spectrometry. The proteins that were subsequently identified contained a higher than average (9.7 versus 5.5%) lysine content and numerous stretches of lysine run-ons, which is a presumed electrophile binding motif. Approximately 50% of these proteins have also been identified as targets for electrophilic adduction by a diverse group of chemicals by other investigators, implying overlapping electrophile adductomes. By identifying a motif targeted by electrophiles it becomes possible to make predictions of proteins that may be targeted for adduction and possible sites on these proteins that are adducted. An understanding of proteins targeted for adduction is essential to unraveling the toxicity produced by these electrophiles.

[1]  Robert P Hanzlik,et al.  Protein targets of reactive metabolites of thiobenzamide in rat liver in vivo. , 2008, Chemical research in toxicology.

[2]  David Bourgais,et al.  PARPs database: A LIMS systems for protein-protein interaction data mining or laboratory information management system , 2007, BMC Bioinformatics.

[3]  Srinivas Malladi,et al.  Quinone electrophiles selectively adduct "electrophile binding motifs" within cytochrome c. , 2007, Biochemistry.

[4]  L. Marnett,et al.  Identification of the protein targets of the reactive metabolite of teucrin A in vivo in the rat. , 2007, Chemical research in toxicology.

[5]  D. Petersen,et al.  Residue-specific adduction of tubulin by 4-hydroxynonenal and 4-oxononenal causes cross-linking and inhibits polymerization. , 2007, Chemical research in toxicology.

[6]  Michael Oellerich,et al.  Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats. , 2007, Biochimie.

[7]  D. Petersen,et al.  4-Hydroxy-2-nonenal Adduction of Extracellular Signal-Regulated Kinase (Erk) and the Inhibition of Hepatocyte Erk-Est–Like Protein-1-Activating Protein-1 Signal Transduction , 2007, Molecular Pharmacology.

[8]  Robert P Hanzlik,et al.  A proteomic analysis of bromobenzene reactive metabolite targets in rat liver cytosol in vivo. , 2007, Chemical research in toxicology.

[9]  T. Williams,et al.  Site-specific arylation of rat glutathione s-transferase A1 and A2 by bromobenzene metabolites in vivo. , 2006, Chemical research in toxicology.

[10]  John A Thompson,et al.  Immunochemical and proteomic analysis of covalent adducts formed by quinone methide tumor promoters in mouse lung epithelial cell lines. , 2005, Chemical research in toxicology.

[11]  M. Salemi,et al.  Characterization of a structurally intact in situ lung model and comparison of naphthalene protein adducts generated in this model vs lung microsomes. , 2005, Chemical research in toxicology.

[12]  R. Beavis,et al.  A method for reducing the time required to match protein sequences with tandem mass spectra. , 2003, Rapid communications in mass spectrometry : RCM.

[13]  T. Monks,et al.  An integrated approach to identifying chemically induced posttranslational modifications using comparative MALDI-MS and targeted HPLC-ESI-MS/MS. , 2003, Chemical Research in Toxicology.

[14]  D. Nerland,et al.  Selective covalent binding of acrylonitrile to Cys 186 in rat liver carbonic anhydrase III in vivo. , 2003, Chemical research in toxicology.

[15]  A. Burlingame,et al.  Attomole Detection of in Vivo Protein Targets of Benzene in Mice , 2002, Molecular & Cellular Proteomics.

[16]  D. Liebler,et al.  Mass spectral characterization of dichloroacetic acid-modified human glutathione transferase zeta. , 2002, Chemical research in toxicology.

[17]  C. Supuran,et al.  Cysteine-modifying agents: a possible approach for effective anticancer and antiviral drugs. , 2002, Environmental health perspectives.

[18]  Jian Cai,et al.  Acrylonitrile irreversibly inactivates glyceraldehyde-3-phosphate dehydrogenase by alkylating the catalytically active cysteine 149. , 2002, Chemico-biological interactions.

[19]  W. Alvord,et al.  Increased serum corticosterone and glucose in offspring of chromium(III)-treated male mice. , 2002, Environmental health perspectives.

[20]  C. Supuran,et al.  Targeting cysteine residues of biomolecules: new approaches for the design of antiviral and anticancer drugs. , 2002, Current medicinal chemistry.

[21]  D. Liebler,et al.  Alkylation and inactivation of human glutathione transferase zeta (hGSTZ1-1) by maleylacetone and fumarylacetone. , 2002, Chemical research in toxicology.

[22]  B. Hill,et al.  Anticancer therapy with novel tubulin-interacting drugs. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[23]  C. Fenselau,et al.  Molecular dynamics simulation of metallothionein-drug complexes. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[24]  J. Jaén,et al.  Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Kleiner,et al.  Immunochemical analysis of quinol-thioether-derived covalent protein adducts in rodent species sensitive and resistant to quinol-thioether-mediated nephrotoxicity. , 1998, Chemical Research in Toxicology.

[26]  H. Kleiner,et al.  Immunochemical detection of quinol--thioether-derived protein adducts. , 1998, Chemical research in toxicology.

[27]  C. Fenselau,et al.  Covalent sequestration of the nitrogen mustard mechlorethamine by metallothionein. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[28]  A. Burlingame,et al.  Identification of the Hepatic Protein Targets of Reactive Metabolites of Acetaminophen in Vivo in Mice Using Two-dimensional Gel Electrophoresis and Mass Spectrometry* , 1998, The Journal of Biological Chemistry.

[29]  N. Lawrence,et al.  Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle , 1998, Medicinal research reviews.

[30]  J. Ware,et al.  Immunochemical detection and identification of protein adducts of diclofenac in the small intestine of rats: possible role in allergic reactions. , 1998, Chemical research in toxicology.

[31]  D. Thompson,et al.  Immunochemical visualization and identification of rat liver proteins adducted by 2,6-di-tert-butyl-4-methylphenol (BHT). , 1997, Chemical research in toxicology.

[32]  J. Zaia,et al.  A binding site for chlorambucil on metallothionein. , 1996, Biochemistry.

[33]  C. Fenselau,et al.  Covalent sequestration of melphalan by metallothionein and selective alkylation of cysteines. , 1995, Biochemistry.

[34]  P Ferrara,et al.  In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. , 1992, Analytical biochemistry.

[35]  T. Monks,et al.  Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. , 1988, Molecular pharmacology.

[36]  T. Monks,et al.  Intra- and extra-cellular formation of metabolites from chemically reactive species. , 1984, Biochemical Society transactions.

[37]  A. Bakka,et al.  Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein. , 1983, Cancer research.

[38]  F. N. Kotsonis,et al.  Increase in hepatic metallothionein in rats treated with alkylating agents. , 1979, Toxicology and applied pharmacology.

[39]  D. Liebler,et al.  Alkylation of cytochrome c by (glutathion-S-yl)-1,4-benzoquinone and iodoacetamide demonstrates compound-dependent site specificity. , 2005, Chemical research in toxicology.

[40]  C. Walker,et al.  Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone. , 2001, Chemical research in toxicology.

[41]  A. Burlingame,et al.  Identification of hepatic protein targets of the reactive metabolites of the non-hepatotoxic regioisomer of acetaminophen, 3'-hydroxyacetanilide, in the mouse in vivo using two-dimensional gel electrophoresis and mass spectrometry. , 2001, Advances in experimental medicine and biology.

[42]  F. Guengerich,et al.  Reactive intermediates in biological systems: what have we learned and where are we going? , 2001, Advances in experimental medicine and biology.